Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of V0355 in Women with Iron Deficiency Anaemia
NCT02518568Phase 1Terminated
- Sponsor
- Pierre Fabre Laboratories
- Start
- Aug 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial of ferrous sulfate in iron deficiency anemia (IDA), sponsored by Pierre Fabre Laboratories. Primary endpoints: Maximum Plasma Concentration up to 24 hours, Time to Maximum Concentration up to 24 hours and 1 more. Started Aug 2015; status: terminated.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02518568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02518568.